Impact of pre-admission oral anticoagulation on ischaemic stroke volume, lesion pattern, and frequency of intracranial arterial occlusion in patients with atrial fibrillation. Issue 11 (20th November 2017)

• Record Type: Journal Article
• Authors: Dietzel, Joanna; Piper, Sophie K; Ruschmann, Rudi; Wollboldt, Christian; Usnich, Tatiana; Hellwig, Simon; Galinovic, Ivana; Audebert, Heinrich J; Endres, Matthias; Villringer, Kersten; Fiebach, Jochen B; Haeusler, Karl Georg
• Is Part Of: Europace. Volume 20:Issue 11(2018)
• Page Start: 1758
• Page End: 1765
• Publication Date: 2017-11-20
• Subjects: Atrial fibrillation -- Magnetic resonance imaging -- Oral anticoagulation -- Stroke lesion pattern -- Stroke volume; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/eux333
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: Therapeutic oral anticoagulation on hospital admission reduces morbidity and mortality after acute ischaemic stroke in patients with atrial fibrillation (AF). The underlying mechanism is not fully understood. In order to assess the impact of INR-level on admission on stroke volume, lesion pattern and the frequency of intracranial arterial occlusion, we analysed serial MRI measurements in AF patients suffering acute ischaemic stroke. Methods and results: This subgroup analysis of the prospective '1000Plus' study included patients with acute ischaemic stroke and known AF or a first episode of AF in hospital. All patients underwent serial brain magnetic resonance imaging. Stroke patients were categorized as follows: Group1, phenprocoumon intake, international normalized ratio (INR) ≥1.7 on admission, no thrombolysis; Group2, INR < 1.7 on admission, thrombolysis; and Group3, INR < 1.7, no thrombolysis. In 98 AF patients {77 ± 9 years, 60% male; median National Institute of Health Stroke Scale [NIHSS] score on admission 5 (interquartile range [IQR] 2–8)} with known AF before admission, territorial infarction was less often found in Group 1 ( n = 20) compared with Group 2 + 3 (20% vs. 47%, P = 0.022). Arterial occlusion rate on admission differed among groups (30%, 75%, and 35%, respectively, P = 0.004) but not between Group 1 vs. Group 2 + 3 (30% vs. 45%, P = 0.31). Median FLAIR volume on Days 5–7 was lower in Group1 compared with Group 2 ( n = 20) [3.2 cm 3 (IQR 1.1–11.3) vs. 18.6 cm 3 (IQR 8.2–49.4); P = 0.009] but not compared with Group 2 + 3 [7.8 cm 3 (IQR 1.6–25.9); P = 0.23]. An INR ≥ 1.7 on admission was not associated with smaller stroke volume in multivariable regression analysis. Adding 57 patients with a first AF episode during the in-hospital stay, similar results were observed in 155 AF patients. Conclusion: In this AF cohort, an INR ≥ 1.7 at stroke onset affects lesion pattern but does not affect significantly lower stroke volume and the frequency of arterial occlusion on admission.